Today: 20 March 2026
Subscribe
Browse Category

Netflix News 15 December 2025 - 28 February 2026

Netflix stock leaps on $2.8 billion breakup fee — here’s what matters before NFLX reopens

Netflix stock leaps on $2.8 billion breakup fee — here’s what matters before NFLX reopens

Netflix shares jumped 13.77% to $96.24 on Friday after the company exited its Warner Bros. Discovery bid and received a $2.8 billion breakup fee from Paramount. The move eased concerns over debt and deal risk. Paramount will proceed with a $110 billion Warner merger. Investors await Monday’s trading and guidance on Netflix’s use of the cash.
28 February 2026
····
Netflix stock pops after-hours as NFLX drops out of Warner Bros bidding war

Netflix stock pops after-hours as NFLX drops out of Warner Bros bidding war

Netflix shares closed up 2.3% at $84.59 and rose another 0.8% after hours Thursday. The company said it will not raise its bid for Warner Bros Discovery after Warner’s board called Paramount Skydance’s $31-a-share offer superior. Netflix had previously agreed to pay $27.75 a share. Focus turns to Warner’s response and Netflix’s plans for its cash.
27 February 2026
···
Netflix stock price faces a fresh test after holiday as Warner deal fight sharpens

Netflix stock price faces a fresh test after holiday as Warner deal fight sharpens

Netflix shares rose 1.33% to $76.87 Friday, rebounding after a sharp drop as Paramount intensified its challenge to Netflix’s Warner Bros. deal with new hires and potential board moves. Paramount named Rene Augustine as SVP of global public policy and held talks with hedge fund manager Matthew Halbower about a possible Warner board seat. U.S. markets are closed Monday for Washington’s Birthday.
15 February 2026
····
Netflix stock price today: NFLX ticks up after hours on insider sale filing — what to watch next week

Netflix stock price today: NFLX ticks up after hours on insider sale filing — what to watch next week

Netflix shares rose 0.4% to $83.49 in after-hours trading Friday after a filing showed co-CEO Gregory Peters plans to sell up to 105,781 shares, worth about $8.77 million. The Senate Judiciary antitrust panel set a Feb. 3 hearing on Netflix’s proposed merger with Warner Bros Discovery. UK politicians urged a full probe of the deal. Paramount Skydance extended its rival offer deadline to Feb. 20.
31 January 2026
··
Netflix stock rises as CEO knocks Paramount’s Warner bid — what Feb. 20 could mean for NFLX

Netflix stock rises as CEO knocks Paramount’s Warner bid — what Feb. 20 could mean for NFLX

Netflix shares rose 3.1% to $86.12 Friday as co-CEO Greg Peters dismissed Paramount’s bid for Warner Bros Discovery, calling it unconvincing. Paramount extended a $30-a-share hostile offer while warning Warner shareholders the Netflix cash payout could fall to $21.40 per share due to debt adjustments. Netflix switched to an all-cash bid this week and paused buybacks to fund the deal.
24 January 2026
····
Netflix stock drops even after Q4 beat as Warner Bros bid freezes buybacks

Netflix stock drops even after Q4 beat as Warner Bros bid freezes buybacks

Netflix shares fell about 3% to $84.64 Wednesday after the company paused buybacks and shifted to an all-cash $27.75 per share bid for Warner Bros Discovery. Netflix secured a $59 billion bridge loan for the deal and projected 2026 revenue growth of 12%-14%. Warner Bros Discovery shares rose 0.8%. Investors focused on deal risks and Netflix’s funding strategy.
21 January 2026
···
Netflix stock slides below $90 as Goldman trims target and Warner bid fight drags on

Netflix stock slides below $90 as Goldman trims target and Warner bid fight drags on

Netflix shares dropped 2% to $88.70 Friday after Goldman Sachs cut its price target, with pressure mounting as Paramount reiterated a higher $30-per-share bid for Warner Bros. Discovery. Paramount’s offer expires Jan. 21, while Warner would owe Netflix a $2.8 billion breakup fee if it exits their deal. Investors await Netflix’s Jan. 20 earnings for clarity on financing and strategy.
9 January 2026
·····
Netflix stock today: NFLX drops nearly 3% as Warner deal drama and earnings near

Netflix stock today: NFLX drops nearly 3% as Warner deal drama and earnings near

Netflix shares closed down 3% at $90.99 Friday, underperforming the broader market as investors weighed its $82.7 billion deal to acquire Warner Bros. Discovery’s studios and streaming assets. Paramount extended its rival $30-per-share bid for Warner Bros. Discovery to Jan. 21. Netflix will report fourth-quarter results Jan. 20.
4 January 2026
·····
Netflix stock edges up into year-end as Fed minutes, Warner deal stay in focus

Netflix stock edges up into year-end as Fed minutes, Warner deal stay in focus

Netflix shares closed up 0.9% at $94.47 Friday, outperforming Disney and Warner Bros. Discovery, as investors weighed risks around its $72 billion deal for Warner’s studio and streaming assets. The company replaced part of its bridge loan with a $5 billion credit facility and two $10 billion term loans. U.S. stocks remain near record highs ahead of Fed minutes due Tuesday. Netflix reports earnings Jan. 20.
29 December 2025
···
Netflix Stock (NFLX) News Today: Market Closed as Wall Street Weighs NFL Streaming Complaints, Warner Deal Financing, and Analyst Targets

Netflix Stock (NFLX) News Today: Market Closed as Wall Street Weighs NFL Streaming Complaints, Warner Deal Financing, and Analyst Targets

Netflix shares closed Friday at $94.47, with after-hours trading near $94.35 and no movement Sunday as U.S. markets remain shut. The company faced criticism over stream quality and production choices during its NFL Christmas Day broadcasts, drawing mixed reviews from viewers and media. Trading volume Friday was about 22 million shares. Netflix’s 52-week range stands at $82.11 to $134.12.
28 December 2025
··
Netflix Stock (NFLX) Weekend Update: Price, Warner Bros. Deal, Analyst Forecasts, and What to Watch When Markets Reopen

Netflix Stock (NFLX) Weekend Update: Price, Warner Bros. Deal, Analyst Forecasts, and What to Watch When Markets Reopen

Netflix shares closed Friday at $94.47, up 0.9%, as U.S. markets shut for the weekend. The stock remains in focus after Netflix agreed to acquire Warner Bros., including HBO Max, in a deal valuing WBD at about $72 billion. Trading volume was active ahead of the holiday break. The S&P 500 is within 1% of 7,000 amid thin year-end trading.
27 December 2025
···
Warner Bros. Discovery (WBD) Series A Stock Today: Paramount’s $30 Bid Gets Larry Ellison Backstop as Netflix Deal Enters Crunch Time

Warner Bros. Discovery (WBD) Series A Stock Today: Paramount’s $30 Bid Gets Larry Ellison Backstop as Netflix Deal Enters Crunch Time

Warner Bros. Discovery stock traded near $28.98 Tuesday as Paramount Skydance amended its $30-per-share all-cash tender offer, adding a $40.4 billion personal guarantee from Oracle’s Larry Ellison. WBD’s board acknowledged receipt but maintained support for Netflix’s rival cash-and-stock deal. Harris Associates, a top WBD shareholder, called the new Paramount terms “not sufficient.”
23 December 2025
·····
Netflix Stock (NFLX) After Hours Today (Dec. 22, 2025): $25B Financing Update, Paramount’s Larry Ellison Move, and What to Watch Before Tuesday’s Open

Netflix Stock (NFLX) After Hours Today (Dec. 22, 2025): $25B Financing Update, Paramount’s Larry Ellison Move, and What to Watch Before Tuesday’s Open

Netflix shares closed Monday at $93.23, down 1.23%, then edged up to $93.31 after hours as investors reacted to news of a financing overhaul tied to its proposed Warner Bros. Discovery deal. The company replaced part of a $59 billion bridge loan with a $5 billion revolving credit facility and two $10 billion term loans. The S&P 500 and Nasdaq rose, contrasting Netflix’s decline.
23 December 2025
···
Netflix Stock (NFLX) News Today — Dec. 21, 2025: Warner Bros. Deal Battle, Analyst Forecasts, and What Investors Watch Next

Netflix Stock (NFLX) News Today — Dec. 21, 2025: Warner Bros. Deal Battle, Analyst Forecasts, and What Investors Watch Next

Netflix last closed at $94.39 per share on Dec. 21, 2025, following a 10-for-1 stock split, giving it a market cap of about $431 billion. The company agreed to acquire Warner Bros. Discovery—including HBO and HBO Max—for $82.7 billion, while Paramount Skydance made a rival $30-per-share bid. Warner’s board recommended shareholders back Netflix’s offer. Regulatory scrutiny is expected.
21 December 2025
····
Netflix Stock (NFLX) After Hours Today (Dec. 18, 2025): Shares Steady Near $94 as Warner Bros. Deal Headlines Build — What to Watch Before Friday’s Open

Netflix Stock (NFLX) After Hours Today (Dec. 18, 2025): Shares Steady Near $94 as Warner Bros. Deal Headlines Build — What to Watch Before Friday’s Open

Netflix closed Thursday at $94.00, down 0.83%, and edged up to $94.04 in after-hours trading. Shares lagged the broader market amid ongoing uncertainty over Netflix’s proposed $82.7 billion acquisition of Warner Bros. assets, which faces regulatory review and a complex closing process expected to extend into 2026.
18 December 2025
···
Netflix Stock (NFLX) News Today: Warner Bros Deal Reaffirmed, Analyst Price Targets Shift, and the 2026 Outlook (Dec. 15, 2025)

Netflix Stock (NFLX) News Today: Warner Bros Deal Reaffirmed, Analyst Price Targets Shift, and the 2026 Outlook (Dec. 15, 2025)

Netflix shares rose about 1% to $95 Monday after co-CEOs told employees the company remains committed to acquiring Warner Bros. Discovery’s studios and streaming business for $72 billion. The deal, expected to close after a WBD spin-off in Q3 2026, would put Netflix into theatrical distribution for the first time. Breakup fees total $5.8 billion for Netflix and $2.8 billion for WBD.
15 December 2025
···
1 2

Stock Market Today

  • Vertex Pharmaceuticals Stock Drops 4.8% Amid Mixed Drug Sales and Pipeline Concerns
    March 20, 2026, 9:36 AM EDT. Vertex Pharmaceuticals' (VRTX) stock fell 4.8% over the past month due to worries about new drugs Journavx and Casgevy underperforming, recent pipeline setbacks, and drug pricing pressures. Despite these challenges, Vertex maintains a strong position in the cystic fibrosis (CF) market, treating about 75% of patients with its five CF medicines, including the robust sales of Trikafta/Kaftrio and Alyftrek. Alyftrek's sales reached $837.8 million in 2025 and are expected to grow with expanded approvals and younger patient use. The company is also advancing an mRNA therapy with Moderna for patients unresponsive to current treatments. Investors face a decision: sell amid short-term concerns or hold given Vertex's strong CF franchise and growth potential.
Go toTop